172 related articles for article (PubMed ID: 4144610)
21. [Tumor immunology].
Cerni CM
Subsid Med; 1974; 2():21-5. PubMed ID: 4606048
[No Abstract] [Full Text] [Related]
22. Immunosuppression and neoplasia. II. Is deficient immunesurveillance the only mechanism by which immunosuppression promotes neoplasia? A speculative review.
Gleichmann E; Gleichmann H
Klin Wochenschr; 1973 Mar; 51(6):260-5 concl. PubMed ID: 4144595
[No Abstract] [Full Text] [Related]
23. [Immunological surveillance and spontaneous carcinogenesis].
Salomon JC
Ann Inst Pasteur (Paris); 1972 Apr; 122(4):669-75. PubMed ID: 4559234
[No Abstract] [Full Text] [Related]
24. Increased incidence of urethan-induced lung adenomas in neonatally thymectmized mice challenged with lymphoid cells.
Trainin N; Linker-Israeli M
Cancer Res; 1969 Oct; 29(10):1840-5. PubMed ID: 4390458
[No Abstract] [Full Text] [Related]
25. Letter: Immune surveillance revisited.
Law LW
J Natl Cancer Inst; 1975 Jan; 54(1):280-2. PubMed ID: 1113309
[No Abstract] [Full Text] [Related]
26. Transplantation behavior of allotransplantable tumor lines derived from immunologically modified hosts.
Parks RC; Jacobs BB
J Natl Cancer Inst; 1975 May; 54(5):1079-83. PubMed ID: 236395
[TBL] [Abstract][Full Text] [Related]
27. Depression of complement activity in tree strains of mice after tumor transfer.
Drake WP; LeGednre SM; Mardiney MR
Int J Cancer; 1973 May; 11(3):719-24. PubMed ID: 4151582
[No Abstract] [Full Text] [Related]
28. Predictive oncology. 3.
Bierman HR
Int Surg; 1973; 58(11):768-73. PubMed ID: 4584400
[No Abstract] [Full Text] [Related]
29. An insight into cancer immunology and immunotherapy.
Thompson RB
Prog Clin Pathol; 1975; 6():159-76. PubMed ID: 1105670
[No Abstract] [Full Text] [Related]
30. Immunosurveillance, regeneration and oncogenesis.
Prehn RT
Prog Exp Tumor Res; 1971; 14():1-24. PubMed ID: 4944395
[No Abstract] [Full Text] [Related]
31. Malignant disease in immunodeficient states in man.
Penn I
Recent Results Cancer Res; 1975; (52):96-106. PubMed ID: 796918
[No Abstract] [Full Text] [Related]
32. Contemporary immunologic considerations in head and neck tumors.
Berlinger NT; Good RA
Otolaryngol Clin North Am; 1974 Oct; 7(3):859-83. PubMed ID: 4607983
[No Abstract] [Full Text] [Related]
33. The elimination of graft-versus-host cells from an immune population. A potential tool in cancer immunotherapy.
Mandel MA; Asofsky R
J Surg Res; 1974 May; 16(5):546-51. PubMed ID: 4151608
[No Abstract] [Full Text] [Related]
34. [Immunological surveillance, immunosuppression T and cancer].
RodrÃguez Paradisi E
Sangre (Barc); 1976; 21(3):523-8. PubMed ID: 788204
[No Abstract] [Full Text] [Related]
35. Diversity of envelope antigens on murine type-C RNA viruses.
Aoki T; Huebner RJ; Chang KS; Sturm MM; Liu M
J Natl Cancer Inst; 1974 Apr; 52(4):1189-97. PubMed ID: 4363704
[No Abstract] [Full Text] [Related]
36. Graft-versus-host alloresponses to treat nonlymphohematopoietic tumors: is there a solid approach?
Sykes M
J Immunother; 2001; 24(2):101-3. PubMed ID: 11265765
[No Abstract] [Full Text] [Related]
37. The present status of tumor immunology.
Fisher B
Adv Surg; 1971; 5():189-254. PubMed ID: 4941820
[No Abstract] [Full Text] [Related]
38. Long-term spontaneous tumor incidence in neonatally thymectomized mice.
Sanford BH; Kohn HI; Daly JJ; Soo SF
J Immunol; 1973 May; 110(5):1437-9. PubMed ID: 4572636
[No Abstract] [Full Text] [Related]
39. Immunologic aspects of malignancy.
Pirofsky B
Am J Obstet Gynecol; 1978 May; 131(2):180-5. PubMed ID: 25584
[TBL] [Abstract][Full Text] [Related]
40. Influence of immunologic competence of the host on metastases induced by the 3LL Lewis tumor in mice.
Carnaud C; Hoch B; Trainin N
J Natl Cancer Inst; 1974 Feb; 52(2):395-9. PubMed ID: 4816002
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
